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Summary
Erythema nodosum leprosum (ENL) is a multisystem reaction which affects some
people with multibacillary (MB) leprosy, but more specifically those with BL or LL
type leprosy. The symptoms of ENL can lead to long term physical, social and
economic losses, although very little is known about the effect of ENL on quality of life.
Methods: A cross-sectional study was conducted in northwest Bangladesh.
A Bengali version of the RAND 36-Item Health Survey 1·0 (SF-36) was administered
to people under treatment for ENL (n ¼ 29) and controls affected by MB leprosy
(n ¼ 46) matched for: sex, treatment status, age, Disability grade at diagnosis,
education level and housing type. Chi Square and Wilcoxon RST were used to
analyse the data using the R statistical package.
Results: Patients with ENL had significantly (P , ·001) worse Health Related
Quality of life (HRQoL) scores on all eight SF-36 health concepts: physical
functioning, pain, role limitations due to physical and emotional limitations,
emotional well-being, social functioning, energy/fatigue, and general health
perceptions. Cohen’s d indicated a large effect (d ¼ ·96 to 1·67). The results are
compared with results of other published works which examined similar populations
Conclusion: HRQoL is significantly impaired in Bangladeshi people suffering from
ENL compared with people with MB leprosy and no ENL. ENL affects all areas of a
person’s HRQoL measured by the SF-36. Health care providers need to spend time
addressing other aspects of a person’s life and not just the physical symptoms.
Correspondence to: Bob Bowers, Rural Health Programme, Nilphamari, Bangladesh (e-mail: rehabwork@
gmail.com)
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Introduction
It is recognised that leprosy may impair quality of life.1 However, leprosy is a complex
syndrome with diverse manifestations which may affect various people’s lives differently.
It would be helpful to know which features of leprosy are most important in this respect,
whether the differences in health-related Quality of Life can be easily measured using a
validated tool (such as SF-36), and whether the effect on quality of life is mitigated by
medical treatment and other interventions.
Erythema nodosum leprosum (ENL), also called Type 2 reaction, occurs in some people
affected by BL and LL type leprosy (leprosy classifications included in multibacillary (MB)
leprosy). ENL has been reported to effect 4–9% of people with BL leprosy and 15–50% of
people with LL.2,3 ENL is diagnosed by crops of tender cutaneous or subcutaneous lesions.4
However, it is a multisystem disorder and other features of the condition include severe pain,
fever, oedema, neuritis, iritis, and orchitis. ENL can lead to physical disability, loss of
earnings5 or an inability to carry out one’s normal social roles. Some people have a single
acute episode of ENL which may last up to 24 weeks, while others may have chronic or
recurrent episodes of ENL continuing for many years.6
Little is known about the level of impairment of quality of life attributable to ENL or how
long this impairment persists. The only known study which has assessed quality of life in
people with ENL is by Yap et al.7 They used the Dermatology Life Quality Index (DLQI) to
assess 48 patients with ENL and compared them to 105 smear positive MB patients without
ENL. They found the patients with ENL had significantly worse DLQI scores both in the total
score and in each of the domains except treatment. A limitation of the DLQI is that it does not
reflect any of the extra-cutaneous features of ENL.
Several studies have assessed quality of life as it relates to leprosy: one study was done in
Bangladesh,1 four in South America,8 – 11 one in Ghana12 and one in India.13 Most of the
studies have used the WHOQOL-bref,1,8,9,11 while one used an alternate version of the
WHOQOL,13 and one used the Short form-20 health survey assessment.12 Santos9 reported a
correlation between increased activity limitation as assessed by the SALSA and lower quality
of life. Costa8 reported lower QOL scores in patients with increased pain. Tsutsumi1 showed
an association between reduced quality of life and increased stigma, lower education, lower
income, and the presence of disability.
As part of a group of studies undertaken by the ENLIST group,14 we investigated the
effect of ENL on health-related quality of life (HRQoL) in people living in Bangladesh. Our
hypothesis was that patients with ENL would have a worse quality of life as measured by the
SF-36. We tested this hypothesis by recruiting patients with ENL and controls without ENL
from a rural leprosy setting in Bangladesh and comparing HRQoL.
Methods
We conducted a cross-sectional study, using a Bengali version of the RAND 36-Item Health
Survey 1·0, administered to individuals who currently or previously suffered from ENL and
to other leprosy-affected people matched for relevant criteria.
The study was carried out by Rural Health Programme (RHP), based at Nilphamari in
northwest Bangladesh. RHP is a well-established programme run by The Leprosy Mission
Bangladesh, providing leprosy control and treatment services as part of the National Leprosy
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Control Programme for four districts with a population of 7·8 million people. Data were
collected between May 2014 and August 2015.
Approval for the study was granted by the Institutional Review Board for northwest
Bangladesh-TLMiB on April 22, 2014. After an explanation of the study in Bengali, eligible
individuals were invited to participate and they gave written informed consent before starting
the study.
The RAND 36-Item Health Survey 1·0 (SF-36)15 – 17 was selected to assess health related
Quality of Life (HRQoL) as it is a validated instrument which has been employed in the
context of other chronic diseases. The SF-36 has been widely used, with citations in over
5000 publications.18 A Bengali translation of the SF-36 was developed by Feroz et al.,19 who
translated and culturally adapted the SF-36 for use with patients with rheumatoid arthritis.
Their study of 125 patients using the Bengali version of the SF-36 revealed good
psychometric properties (Cronbach’s a . 0·78 and test-retest reliability . 0·82).
The SF-36 was previously translated into Bengali and validated in that form.19 The Feroz
et al.19 Bengali translation of the SF-36 was back translated from Bengali to English by
selected RHP staff to check for local comprehensibility. Minor changes were made in the
Bengali wording of four questions as confusion arose while training the staff in administering
prior version of the SF-36.
Cronbach Alpha of the final modified Bengali version of the SF-36 was calculated for
each scale to confirm the consistency of items within each scale. The Cronbach Alpha ranged
from ·78 to ·92. These values are consistent with the SF-36 reliability norms20 and what was
reported by Feroz.19
Study participants were selected from eleven RHP field clinics in Nilphamari and
Rangpur Districts historically known to diagnose and treat more ENL cases. It was decided to
only use 11 of 26 clinics in order to increase reliability with a small number of staff doing a
greater number of assessments. All staff involved in the study attended a 2-day training for
orientation and practice in administering the SF-36 in a reliable way.
As this field programme supports the national leprosy elimination programme, diagnosis
of leprosy and of MB classification is according to national guidelines, which both follow the
WHO operational criteria.4 A Medical officer confirms the diagnosis in each case. Registered
leprosy cases are also clinically classified by the trained field staff using Ridley Jopling
criteria.21 ENL was clinically defined as crops of tender cutaneous/subcutaneous lesions in a
person diagnosed with leprosy. Three categories of ENL were recognised; acute ENL lasting
less than 24 weeks, recurrent ENL referring to a subsequent episode beginning 28 days or
more after completing anti-reaction treatment, and chronic ENL lasting more than 6 months
with no treatment free interval of over 27 days.22
All patients at the selected field clinics who were newly diagnosed with ENL, or currently
under treatment for ENL were requested to join the study. Following signed informed consent
eligible patients were enrolled in the study, provided they were over age 15 years.
The next two people presenting at the clinic with a diagnosis of MB leprosy who did not
have ENL were enrolled as control subjects, if they were willing to participate. Individuals
with MB leprosy who did not have ENL were eligible for inclusion in the control group
whether or not still on MDT.
Individuals in the control group were matched, as far as possible, on the following
variables: a) sex, b) WHO disability grade at diagnosis, b) age, c) treatment status (under
treatment with multidrug therapy or released from treatment (RFT) after completing
multidrug therapy), d) educational level (literate/illiterate), and e) socio-economic level as
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judged by housing type. Other variables, such RJ classification and time since MDT
diagnosis, were recorded for comparison.
All study participants were interviewed using the SF-36, at the local clinic, by a staff
member trained in administering the SF-36. The SF-36 addresses eight specific health
concepts, or scales: physical functioning, role limitation due to physical health problems, role
limitation due to emotional problems, emotional well-being, social functioning, energy/
fatigue, pain, and general health perception. This instrument is straightforward to use and
appropriate for people affected by leprosy.17,23,24
Data were entered into a Microsoft Access database prepared by one of the authors, which
calculated the health related concept scores. Scores were all transformed to a 0–100 scale for
ease of comparison. Higher scores of the SF-36 indicate a more favourable health state. Data
were imported into the R statistical package25 where the graphical interface “Deducer” was
used.26 Data were analysed using non-parametric statistical procedures.27 Data describing
demographic and health status were coded as categorical variables and compared using Chi
Square, while SF-36 scores were analysed using a Wilcoxon Rank Sum test. Cohen’s d effect
size was calculated using G*Power.28
Results
A sample of 29 individuals with ENL and 46 MB controls participated in the study. Table 1
lists the characteristics of the two groups of subjects. There were no significant differences
between the two groups, according to the selected criteria: sex, age groups, MDT treatment
status, disability status, literacy, or economic status (as assessed by construction materials
used in house).
The only significant difference (P , ·001) between the groups is Ridley-Jopling (RJ)
classification which was not a variable preselected for matching. Table 1 shows that most of
the control group was classified BT, while most of the people with ENL were classified LL.
Table 2 lists characteristics of the ENL group’s treatment and impairment. Most of the
individuals with ENL had already been treated for ENL (83%) when interviewed, while the
remaining 17% were newly diagnosed. The majority of those with ENL had been on
treatment for less than 6 months, although one person had been treated for over 4 years.
Current treatment consisted of prednisolone (41%) or prednisolone plus clofazimine (41%)
while no treatment information was recorded in the remaining five cases. Finally, nerve
function impairment was present in 55% of the subjects, with 10% of the nerve function
impairment being recent (up to 6 months duration) and the remainder being longstanding.
Amongst the ENL cases, 59% had acute ENL, 24% had recurrent ENL and 14% had chronic
ENL (Table 2). No subgroup analysis was attempted in this cross-sectional study as sample
size was insufficient.
Subjects with ENL had significantly lower mean HRQoL scores in all scales of the SF-36
than control subjects (Table 3). Cohen’s d standardised effect size is above ·80 on all scales,
which is typically considered a large effect. Subjects with ENL had significantly lower scores
in the areas of physical functioning, pain, physical and emotional role limitations, emotional
well-being, social functioning, energy/fatigue, and general health perceptions. Figure 1
compares scores on all scales for the two cohorts using box plots.
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Discussion
This study demonstrates that in Bangladesh people with ENL have a lower HR-QOL as
measured by the SF-36 as compared to individuals with MB leprosy with no ENL. Individuals
with ENL had significantly lower HR-QOL scores in all domains compared to matched
controls.
The scales showing the largest differences between those with ENL and the controls were
the two role limitation domains (physical and emotional) with average scores differing by 48
and 57 points respectively. These subjects are having difficulty performing work or daily
activities as a result of physical and emotional problems.
The other scales with a score change of more than 40 points were social functioning and
bodily pain. Lower social functioning scores are associated with significant interference with
social activities, while lower bodily pain scores are associated with severe pain which limits
their engagement in life.
The clinical implications of this finding are that healthcare providers may need to spend
more time addressing the needs of patients with ENL. This will take time and resources but is
an important part of patient care. Since ENL can last for many months or even years, there is
a need to address impairment in different aspects of the person’s life (not only physical
symptoms) including relationships, economic situation and mental health.
Table 1. Chi-Square tests of demographic and disease status in ENL cases and controls
ENL cases (n ¼ 29) Controls (n ¼ 46)
Number Percent Number Percent P value
Sex 0·64
Male 24 83% 36 78%
Female 5 17% 10 22%
Age Groups 0·11
15–30 14 48% 17 37%
31–45 7 24% 22 48%
$46 8 28% 7 15%
MDT treatment status 0·53
RFT 18 69% 35 76%
Under treatment 8 31% 11 24%
WHO Disability Grade 0·68
Grade 0 12 41% 22 48%
Grade 1 11 38% 13 28%
Grade 2 6 21% 11 24%
Literate 0·43
Yes 13 45% 23 50%
No 15 52% 23 50%
Housing construction materials 0·34
Durable (tin or concrete) 18 62% 23 52%
Semi-durable (mixed materials) 5 17% 5 11%
Non-durable (straw/bamboo) 6 21% 16 36%
RJ Classification ,0·001
BT 0 0% 31 68%
BB 0 0% 1 2%
BL 6 21% 11 24%
LL 23 79% 2 4%
PN 0 0% 1 2%
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Figure 2 graphically compares the mean and standard deviations reported in four studies
which assessed quality of life using the SF-36. The studies were collected as an exploratory
review of the literature. Studies were primarily sought which used the SF-36 in the context of
leprosy or a Bangladesh population, although the results of the vasculitides studies29 seemed
Table 2. Characteristics of ENL cases (n ¼ 29)
Count Percent
Treatment status
New episode 5 17%
On treatment for ENL 22 76%
Previous ENL 2 7%
Type of ENL
Acute 17 59%
Recurrent 7 24%
Chronic 4 14%
Current treatment
Prednisolone 12 41%
Prednisolone plus clofazimine 12 41%
Other 1 4%
Not recorded 4 14%
ENL treatment duration
,6 months 17 59%
6–12 months 5 17%
13–24 months 3 10%
25–36 months 1 4%
37–48 months 0 0%
49–60 months 1 3%
Not recorded 2 7%
Nerve function impairment (NFI)
None 13 45%
Recent (#6 months) 3 10%
Old (.6 months) 13 45%
Table 3. Scores on SF-36 (average/range) comparing ENL cases with other MB cases
ENL cases Controls
P value Effect size dn M SD n M SD
Total score
Individual health concepts
physical functioning 29 65·3 24·1 46 85·6 17·7 ,0·001 0·96
bodily pain 29 35·7 32·3 46 78·7 22·7 ,0·001 1·54
role limitations due to physical health
problems
29 25·0 31·3 46 73·3 32·2 ,0·001 1·52
role limitations due to personal or
emotional problems
29 24·1 38·7 46 81·5 35·2 ,0·001 1·55
emotional well-being 29 41·0 22·2 46 70·7 19·3 ,0·001 1·43
social functioning 29 42·7 31·9 46 86·7 19·3 ,0·001 1·67
energy/fatigue 29 36·2 23·5 46 67·4 21·9 ,0·001 1·38
general health perceptions 29 35·0 20·5 46 58·0 23·4 ,0·001 1·05
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germane and were included as well. The studies noted in Figure 2 are described in greater
detail in the following paragraphs.
Other authors, using the SF-36, have reported reduced quality of life in individuals
suffering from other chronic disabling conditions such as ENL. These would include
inflammatory disorders with a fluctuating and unpredictable course, such as primary systemic
vasculitis,29 rheumatoid arthritis,19 and lymphatic filariasis.30 Koutantji29 reports on
vasculitides, which are similar to ENL in that they are characterised by organ damage due to
multisystem inflammatory episodes which require immunosuppression. However, the
population studied is from the United Kingdom, so the results are not easily compared with
our study. One study19 was carried out in Bangladesh amongst people with rheumatoid
arthritis. They translated and validated the Bengali version of the SF 36 after overcoming
issues dealing with concepts which were unfamiliar in Bangladesh. People with rheumatoid
arthritis showed a low score specifically in domains of physical functioning, bodily pain and
role limitations due to physical health. The findings are similar to the present study examining
ENL in terms of low scores in role limitations due to physical health and pain.
Lustosa10 used the SF-36 tool to assess health-related quality of life among 107
participants who were on treatment for leprosy. Analysis revealed five factors which affected
quality of life: late diagnosis, MB classification, treatment for reaction (although the type of
reaction was not specified), disability Grade 2 and self-reported experience of discrimination.
As seen in Figure 2, the scores for all individuals in the Lustosa study were very similar to the
scores found in the control group for this study. Although there was a worsening of scores for
patients with Grade 2 disability or leprosy reaction in the Lustosa study, the amount of change
was less than that seen in the current study. The results of this Brazilian study were similar to
ours with lower scores on every scale for reaction subjects compared with controls, and the
Figure 1. Boxplot comparison of control group and ENL patients for each SF-36 scale.
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largest difference observed in the role limitations due to either physical functioning or
emotional issues.
Comparison of quality of life assessed using different tools can be difficult. In
Bangladesh, several studies assessed quality of life using the Bengali version of the World
Figure 2. Comparison of the mean and standard deviation of SF-36 scores for studies mentioned in the discussion.
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Health Organization Quality of life (WHOQOL-bref) assessment.31 – 33 Syed32 looked at
people with chronic arsenic poisoning and found significantly lower QOL scores on all
WHOQOL domains for arsenic patients than for the non-patient matched controls.
Thomas34 used three tools for assessing quality of life in patients with lymphatic filariasis
(which causes some disabilities similar to those associated with leprosy). Their study in
Kerala (India) showed that patients with Filaria had lower HRQoL scores than the control
group using each QOL tool, although the SF-36 was not one of them.
LIMITATIONS OF THIS STUDY
The research design did not use RJ classification as an inclusion or exclusion criterion of
the participants. It may have been difficult to find an adequate number of individuals for the
control group had it been matched, but the issue was not addressed in advance. The
individuals in the ENL group were predominantly LL (79%), while those in the control group
were predominantly BT (67%) with only 4% having an LL classification. Smear negative BT
cases are not at risk of ENL reaction, although they may suffer from Type 1 reaction and
neuritis which might impair their quality of life. It is not known whether individuals with
uncomplicated BL/LL may have features which would adversely, or positively, affect their
HRQoL either relative to having ENL or relative to uncomplicated MB cases with BB or BT
classification, or compared with MB individuals who had Type 1 reaction.
The ENL cases were not interviewed prior to the onset of ENL, so we do not know their
personal baseline level of health-related Quality of life. The tool considers the respondents’
condition over preceding 1 month, not just on the day of the interview. Sequential
measurements of health-related Quality of Life before and during treatment and after
recovery would be useful. Now that this cross-sectional study has demonstrated a sizeable
impairment, planning such long-term cohort observations would be justified. The patient on
treatment for ENL might have well-controlled ENL at the time of the study. Future studies
should have an objective assessment of ENL severity on the day of the HRQol assessment so
that this can be incorporated into the findings.
Quality of life may be markedly influenced in some of these subjects by presence of other
illnesses/disabilities, such as diabetes, as well as other socio-economic problems, and the
patient‘s level of understanding of his/her disease. The sample size did not allow for
comparisons of subgroups.
It would have been helpful to have background data on healthy members of a local
population with similar socioeconomic level, such as neighbours of subjects. Background
population normed scores on the SF-36, were not available for the specific regional population
from which leprosy affected subjects were drawn.
Conclusion
Health related Quality of life is seriously impaired in Bangladeshi people suffering from ENL
reaction, in comparison with people with leprosy who do not have ENL. ENL has a
significant impact on all areas of a person’s health-related quality of life. The areas most
affected are their ability to be productive and take care of daily tasks. The adverse effect on
HRQol is of a similar order to that reported by various authors concerning leprosy-affected
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people, as well as to that experienced in other chronic inflammatory or disabling disorders as
reported in other studies.
Any future studies of treatment of ENL should include an assessment of change in QOL
before treatment and after recovery as one of the outcome measures. It would be interesting to
repeat the study using the SALSA35 and P-Scale36 to see if a correlation exists between SF36
domain scores and assessments of activity or participation restriction.
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